Cite
HARVARD Citation
Ravassa, S. et al. (2018). Biomarker‐based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo‐DHF trial. European journal of heart failure. pp. 1290-1299. [Online].